Skip to main content
. 2019 Jul 3;70(10):2062–2072. doi: 10.1093/cid/ciz589

Table 1.

Baseline Characteristics of Patients by Treatment Group

Treatment Arm
Characteristic Arm A (N = 105)a Arm B (N = 84) Arm C
(N = 82)
Arm D (N = 106)a
Age, y
 Median (IQR) 47.2 (39.8–52.4) 46.0 (41.0–52.2) 47.9 (43.3–51.5) 45.8 (38.2–51.7)
 [min–max] [20.4–70.5] [21.6–74.6] [31.5–70.8] [22.5–67.3]
Gender, n (%)
 Female 20 (19.0) 15 (17.9) 13 (15.9) 17 (16.0)
 Male 85 (81.0) 69 (82.1) 69 (84.1) 89 (84.0)
BMI, n 103 81
 Median (IQR), kg/m2 25.4 (23.1–29.2) 25.6 (23.3–29.2) 26.3 (24.4–29.6) 25.4 (23.0–27.8)
 [min–max], kg/m2 [16.7–42.0] [18.8–52.2] [16.7–46.3] [17.9–43.7]
Systolic blood pressure, n 81
 Mean (SD), mm Hg 126.8 (13.9) 124.4 (14.2) 126.9 (14.3) 124.8 (15.4)
 [min–max], mm Hg [100.0–160.0] [100.0–162.0] [92.0–158.0] [100.0–172.0]
Diastolic blood pressure, mmHg
 Mean (SD) 80.0 (10.7) 78.2 (11.2) 79.7 (9.9) 78.6 (11.1)
 [min–max] [60.0–122.0] [56.0–107.0] [54.0–102.0] [55.0–107.0]
Respiratory rate, n 102 83 76 103
 Mean (SD), breaths/min 15.6 (2.9) 15.9 (4.0) 16.0 (4.2) 16.5 (3.4)
 [min–max], breaths/min [10.0–28.0] [10.0–41.0] [10.0–37.0] [10.0–28.0]
Waist circumference, n 101 83 79 102
 Mean (SD), cm 93.5 (11.8) 94.6 (14.7) 97.1 (12.2) 93.0 (11.6)
 [min–max], cm [65.0–137.0] [66.0–145.0] [70.0–143.0] [67.5–122.0]
Thigh circumference, n 101 82 77 102
 Mean (SD), cm 50.8 (7.5) 52.3 (7.7) 51.8 (6.0) 49.6 (8.5)
 [min–max], cm [33.5–80.0] [39.0–90.5] [37.0–69.0] [22.7–84.0]
eGFR,b n 50 41 38 54
 Mean (SD) [min–max] mL/min per 1.73m2 79.8 (13.6) [45.0–129.0] 79.9 (10.8) [60.0–105.0] 77.9 (10.5) [62.0 –107.6] 81.4 (14.5) [53.0 –‑ 122.0]
 <60, n (%) 0 (0.0) 0 (0.0) 0 (0.0) 1 (0.9)
 <90, n (%) 0 (1.0) 0 (0.0) 0 (0.0) 0 (0.0)
 >60, n (%) 24 (22.9) 23 (27.4) 25 (30.5) 22 (20.8)
 >90, n (%) 28 (26.7) 19 (22.6) 19 (23.2) 28 (26.4)

Abbreviations: BMI, body mass index; eGFR, estimated glomerular filtration rate; IQR, interquartile range; min–max, minimum–maximum; SD, standard deviation.

aArm A and arm D were continued into the second stage of the trial; hence, the difference in sample size between these arms and the other 2 arms (arms B and C) of the trial.

bSome data are presented in both continuous and categorical form due to there being upper and lower limits of measurement.